Jamie Konschnik
Nurse Practitioner · Wilkes Barre, PANPI 1578089884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 478 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Vifor Pharma, Inc. at 24.3% of the total. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 478 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$2K
- Bayer$2K
- Boehringer Ingelheim$741
- Amgen$642
- Calliditas Therapeutics US Inc.$604
- AstraZeneca$523
- plus $3K from 20 others
What the payments were for
- Food & beverage$9,33299%
- Education$991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 132 | $2,295 |
| Bayer | 79 | $1,536 |
| Boehringer Ingelheim | 34 | $741 |
| Amgen | 22 | $642 |
| Calliditas Therapeutics US Inc. | 24 | $604 |
| AstraZeneca(2 entities) | 26 | $523 |
| Ardelyx, Inc. | 17 | $407 |
| Daiichi Sankyo Inc. | 28 | $399 |
| GSK | 23 | $354 |
| Akebia Therapeutics Inc | 16 | $276 |
| Fresenius USA Marketing, Inc. | 10 | $198 |
| Mallinckrodt Hospital Products Inc. | 9 | $191 |
| Otsuka America Pharmaceutical, Inc. | 11 | $190 |
| Kyowa Kirin, Inc. | 7 | $173 |
| Travere Therapeutics, Inc. | 7 | $155 |
| Novo Nordisk | 8 | $151 |
| Nxstage Medical, Inc. | 2 | $120 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $77 |
| OPKO Pharmaceuticals, LLC | 4 | $66 |
| Lilly USA, LLC | 3 | $64 |
| Scpharmaceuticals Inc. | 3 | $61 |
| Novartis | 2 | $56 |
| Ultragenyx Pharmaceutical Inc. | 3 | $54 |
| Pfizer | 2 | $36 |
| Medtronic | 1 | $32 |
| Apellis Pharmaceuticals, Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,431 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuryxiaFerric Citrate | 17 | $43,669 |
| VeltassaPatiromer Calcium Sorbitex | 24 | $21,865 |
| KerendiaFinerenone | 23 | $19,210 |
| JardianceEmpagliflozin | 28 | $12,047 |
| Sevelamer Carbonate | 32 | $6,013 |
| Calcium Acetate | 49 | $5,167 |
| Potassium Chloride | 47 | $2,889 |
| Calcitriol | 203 | $2,106 |
| Cinacalcet Hcl | 21 | $1,508 |
| Amlodipine Besylate | 106 | $1,101 |
| Metoprolol Succinate | 32 | $746 |
| Clonidine Hcl | 73 | $731 |
| Hydralazine Hcl | 36 | $700 |
| Losartan Potassium | 64 | $639 |
| Furosemide | 96 | $625 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Akebia Therapeutics IncAuryxia | $276 | $43,66917 claims |
| BayerKerendia | $1,536 | $19,21023 claims |
| Boehringer IngelheimJardiance | $741 | $12,04728 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Wilkes Barre
- Caroline DerichemondWilkes Barre$10K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.